Long Term Debt Summary of Tibet Rhodiola Pharmaceutical Holding Co.

Tibet Rhodiola Pharmaceutical Holding Co.'s latest annual long term debt in 2023 was 1.12 Million CNY , down -1.67% from previous year.
Tibet Rhodiola Pharmaceutical Holding Co.'s latest quarterly long term debt in 2024 Q2 was 1.08 Million CNY , down 0.0% from previous quarter.
Tibet Rhodiola Pharmaceutical Holding Co. reported annual long term debt of 1.14 Million CNY in 2022, down -38.54% from previous year.
Tibet Rhodiola Pharmaceutical Holding Co. reported annual long term debt of 1.86 Million CNY in 2021, down -82.12% from previous year.
Tibet Rhodiola Pharmaceutical Holding Co. reported quarterly long term debt of - CNY for 2024 Q3, down 0.0% from previous quarter.
Tibet Rhodiola Pharmaceutical Holding Co. reported quarterly long term debt of 1.08 Million CNY for 2024 Q2, down 0.0% from previous quarter.

Annual Long Term Debt Chart of Tibet Rhodiola Pharmaceutical Holding Co. (2023 - 1996)

Historical Annual Long Term Debt of Tibet Rhodiola Pharmaceutical Holding Co. (2023 - 1996)

Year	Long Term Debt	Long Term Debt Growth
2023	1.12 Million CNY	-1.67%
2022	1.14 Million CNY	-38.54%
2021	1.86 Million CNY	-82.12%
2020	10.41 Million CNY	1983.01%
2019	500 Thousand CNY	0.0%
2018	500 Thousand CNY	0.0%
2017	- CNY	-100.0%
2016	1.00 CNY	0.0%
2015	1.00 CNY	0.0%
2014	1.00 CNY	0.0%
2013	- CNY	0.0%
2012	- CNY	0.0%
2011	- CNY	0.0%
2010	- CNY	0.0%
2009	- CNY	0.0%
2008	- CNY	0.0%
2007	- CNY	0.0%
2006	- CNY	0.0%
2005	- CNY	0.0%
2004	- CNY	0.0%
2003	- CNY	0.0%
2002	- CNY	0.0%
2001	- CNY	-100.0%
2000	30 Million CNY	0.0%
1999	- CNY	-100.0%
1998	29.16 Million CNY	12.04%
1997	26.02 Million CNY	0.0%
1996	- CNY	0.0%

Year	Long Term Debt	Long Term Debt Growth
2024 Q1	2.01 Million CNY	0.0%
2024 Q3	- CNY	0.0%
2024 Q2	1.08 Million CNY	0.0%
2023 Q1	864.43 Thousand CNY	-24.48%
2023 Q2	1.02 Million CNY	18.67%
2023 FY	1.12 Million CNY	-1.67%
2023 Q3	1.96 Million CNY	91.38%
2023 Q4	1.12 Million CNY	-42.68%
2022 Q4	1.14 Million CNY	38.81%
2022 FY	1.14 Million CNY	-38.54%
2022 Q1	1.93 Million CNY	3.99%
2022 Q2	1.28 Million CNY	-33.55%
2022 Q3	824.56 Thousand CNY	-35.92%
2021 Q3	3.88 Million CNY	-16.99%
2021 Q4	1.86 Million CNY	-52.01%
2021 FY	1.86 Million CNY	-82.12%
2021 Q1	3.31 Million CNY	-68.21%
2021 Q2	4.67 Million CNY	41.17%
2020 Q4	10.41 Million CNY	559153309705830500.0%
2020 FY	10.41 Million CNY	1983.01%
2020 Q1	- CNY	-100.0%
2020 Q2	- CNY	0.0%
2020 Q3	- CNY	0.0%
2019 Q2	500 Thousand CNY	0.0%
2019 Q1	500 Thousand CNY	0.0%
2019 FY	500 Thousand CNY	0.0%
2019 Q4	500 Thousand CNY	0.0%
2019 Q3	500 Thousand CNY	0.0%
2018 FY	500 Thousand CNY	0.0%
2018 Q4	500 Thousand CNY	0.0%
2018 Q3	500 Thousand CNY	0.0%
2018 Q2	- CNY	-100.0%
2018 Q1	1.00 CNY	0.0%
2017 Q3	613.61 Million CNY	-4.23%
2017 FY	- CNY	-100.0%
2017 Q4	- CNY	-100.0%
2017 Q1	- CNY	-100.0%
2017 Q2	640.7 Million CNY	0.0%
2016 FY	- CNY	0.0%
2016 Q3	- CNY	-100.0%
2016 Q1	- CNY	-100.0%
2016 Q4	1.00 CNY	0.0%
2016 Q2	1.00 CNY	0.0%
2015 Q3	1.00 CNY	0.0%
2015 FY	- CNY	0.0%
2015 Q1	- CNY	-100.0%
2015 Q4	1.00 CNY	0.0%
2015 Q2	- CNY	0.0%
2014 Q2	- CNY	0.0%
2014 Q4	1.00 CNY	0.0%
2014 FY	- CNY	0.0%
2014 Q1	- CNY	100.0%
2014 Q3	- CNY	0.0%
2013 Q1	- CNY	0.0%
2013 Q2	- CNY	0.0%
2013 FY	- CNY	0.0%
2013 Q4	-19.03 Million CNY	0.0%
2013 Q3	- CNY	0.0%
2012 Q2	- CNY	0.0%
2012 Q3	- CNY	0.0%
2012 FY	- CNY	0.0%
2012 Q4	- CNY	0.0%
2012 Q1	- CNY	0.0%
2011 Q1	- CNY	0.0%
2011 FY	- CNY	0.0%
2011 Q2	- CNY	0.0%
2011 Q3	- CNY	0.0%
2011 Q4	- CNY	0.0%
2010 Q1	- CNY	0.0%
2010 FY	- CNY	0.0%
2010 Q4	- CNY	0.0%
2010 Q3	- CNY	0.0%
2010 Q2	- CNY	0.0%
2009 Q3	- CNY	0.0%
2009 Q1	- CNY	0.0%
2009 Q4	- CNY	0.0%
2009 FY	- CNY	0.0%
2009 Q2	- CNY	0.0%
2008 Q4	- CNY	0.0%
2008 Q2	- CNY	0.0%
2008 FY	- CNY	0.0%
2008 Q1	- CNY	0.0%
2008 Q3	- CNY	0.0%
2007 Q4	- CNY	0.0%
2007 Q1	- CNY	0.0%
2007 FY	- CNY	0.0%
2007 Q2	- CNY	0.0%
2007 Q3	- CNY	0.0%
2006 FY	- CNY	0.0%
2006 Q4	- CNY	0.0%
2006 Q3	- CNY	0.0%
2006 Q2	- CNY	0.0%
2006 Q1	- CNY	0.0%
2005 FY	- CNY	0.0%
2005 Q1	- CNY	0.0%
2005 Q2	- CNY	0.0%
2005 Q3	- CNY	0.0%
2005 Q4	- CNY	0.0%
2004 Q4	- CNY	0.0%
2004 Q3	- CNY	0.0%
2004 FY	- CNY	0.0%
2004 Q2	- CNY	0.0%
2004 Q1	- CNY	0.0%
2003 Q3	- CNY	0.0%
2003 Q1	- CNY	0.0%
2003 FY	- CNY	0.0%
2003 Q2	- CNY	0.0%
2003 Q4	- CNY	0.0%
2002 Q2	- CNY	0.0%
2002 Q3	- CNY	0.0%
2002 Q4	- CNY	0.0%
2002 FY	- CNY	0.0%
2002 Q1	- CNY	0.0%
2001 Q2	30 Million CNY	0.0%
2001 Q4	- CNY	0.0%
2001 FY	- CNY	-100.0%
2000 Q2	- CNY	0.0%
2000 Q4	30 Million CNY	0.0%
2000 FY	30 Million CNY	0.0%
1999 Q2	29.16 Million CNY	0.0%
1999 Q4	- CNY	0.0%
1999 FY	- CNY	-100.0%
1998 FY	29.16 Million CNY	12.04%
1998 Q4	29.16 Million CNY	0.0%
1997 FY	26.02 Million CNY	0.0%
1996 FY	- CNY	0.0%

Peer Long Term Debt Comparison of Tibet Rhodiola Pharmaceutical Holding Co.

Name	Long Term Debt	Long Term Debt Difference
Guangxi Wuzhou Zhongheng Group Co.,Ltd	553.47 Million CNY	99.797%
Yabao Pharmaceutical Group Co., Ltd	3.36 Million CNY	66.596%
ZhuZhou QianJin Pharmaceutical Co.,Ltd	38.46 Million CNY	97.074%
Tasly Pharmaceutical Group Co., Ltd	1.41 Billion CNY	99.92%
Jiangsu Kanion Pharmaceutical Co.,Ltd.	1.92 Million CNY	41.551%
Hubei Jumpcan Pharmaceutical Co., Ltd.	1.43 Million CNY	21.541%
Shandong Lukang Pharmaceutical Co.,Ltd.	1.3 Billion CNY	99.914%
North China Pharmaceutical Company Ltd.	4.08 Billion CNY	99.972%
Zhejiang Shengda Bio-Pharm Co., Ltd.	144 Million CNY	99.218%
Heilongjiang ZBD Pharmaceutical Co., Ltd.	1.29 Billion CNY	99.913%
Dali Pharmaceuticalco.,Ltd	14.84 Million CNY	92.421%
Guobang Pharma Ltd.	451.7 Million CNY	99.751%
ChengDu ShengNuo Biotec Co.,Ltd.	189.19 Million CNY	99.405%
Changchun BCHT Biotechnology Co.	-9.85 Million CNY	111.418%
China Animal Husbandry Industry Co., Ltd.	899.03 Million CNY	99.875%
Tianjin Tianyao Pharmaceuticals Co., Ltd.	277 Million CNY	99.594%
Kangmei Pharmaceutical Co., Ltd.	188.16 Million CNY	99.402%
Zhejiang Starry Pharmaceutical Co.,Ltd.	734.44 Million CNY	99.847%
Shandong Buchang Pharmaceuticals Co., Ltd.	2.09 Billion CNY	99.946%
Shanghai Haoyuan Chemexpress Co., Ltd.	229.23 Million CNY	99.509%
Zhejiang Huahai Pharmaceutical Co., Ltd.	4.02 Billion CNY	99.972%
Harbin Pharmaceutical Group Co., Ltd.	32.62 Million CNY	96.551%
Zhejiang Medicine Co., Ltd.	230.54 Million CNY	99.512%
HPGC Renmintongtai Pharmaceutical Corporation	29.4 Million CNY	96.173%
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited	241.03 Million CNY	99.533%
Lionco Pharmaceutical Group Co.,Ltd.	445.18 Million CNY	99.747%
Humanwell Healthcare (Group) Co.,Ltd.	1.65 Billion CNY	99.932%
Ginwa Enterprise (Group) Inc.	5.42 Million CNY	79.271%
KPC Pharmaceuticals, Inc.	107.56 Million CNY	98.954%
Zhejiang Shapuaisi Pharmaceutical Co.,Ltd.	70.75 Million CNY	98.409%
Jiangsu Jibeier Pharmaceutical Co., Ltd.	- CNY	-Infinity%
Ningbo Menovo Pharmaceutical Co., Ltd.	759.64 Million CNY	99.852%
Zhejiang Jiuzhou Pharmaceutical Co., Ltd	389.05 Million CNY	99.711%
Nanjing Well Pharmaceutical Group Co.,Ltd.	104.06 Million CNY	98.919%
Henan Lingrui Pharmaceutical Co., Ltd.	6.96 Million CNY	83.835%
Joincare Pharmaceutical Group Industry Co.,Ltd.	3.12 Billion CNY	99.964%
China Resources Double-Crane Pharmaceutical Co.,Ltd.	29.94 Million CNY	96.242%
Chongqing Taiji Industry(Group) Co.,Ltd	341.6 Million CNY	99.671%
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited	3.32 Billion CNY	99.966%
China National Medicines Corporation Ltd.	205.07 Million CNY	99.451%
Shenzhen Chipscreen Biosciences Co., Ltd.	1.02 Billion CNY	99.89%
Guizhou Yibai Pharmaceutical Co., Ltd.	387.22 Million CNY	99.709%
Zhongzhu Healthcare Holding Co.,Ltd	12.76 Million CNY	91.183%
Beijing Tongrentang Co., Ltd	1.42 Billion CNY	99.921%
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd.	10.95 Million CNY	89.725%
Jianmin Pharmaceutical Group Co.,Ltd.	30.29 Million CNY	96.285%
Tibet Weixinkang Medicine Co., Ltd.	3.81 Million CNY	70.529%
CanSino Biologics Inc.	1.07 Billion CNY	99.895%
Zhejiang Hisun Pharmaceutical Co., Ltd.	2.39 Billion CNY	99.953%
Shanghai Jiaoda Onlly Co.,Ltd	120.22 Million CNY	99.064%
Jiang Zhong Pharmaceutical Co.,Ltd	1.04 Million CNY	-7.419%
Mayinglong Pharmaceutical Group Co., LTD.	128.45 Million CNY	99.124%
Cisen Pharmaceutical Co., Ltd.	132.53 Million CNY	99.151%
Zhejiang Cheng Yi Pharmaceutical Co., Ltd.	316.84 Million CNY	99.645%
Hunan Warrant Pharmaceutical Co.,Ltd	17.1 Million CNY	93.421%
Shanghai Fosun Pharmaceutical (Group) Co., Ltd.	13.5 Billion CNY	99.992%
Hunan Fangsheng Pharmaceutical Co., Ltd.	174 Million CNY	99.353%
Shaanxi Kanghui Pharmaceutical Co., Ltd.	283.87 Million CNY	99.604%
Henan Taloph Pharmaceutical Stock Co.,Ltd	183.8 Million CNY	99.388%
Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd	512.37 Million CNY	99.78%
Beijing Sun-Novo Pharmaceutical Research Co., Ltd.	40.62 Million CNY	97.23%
Shanghai Shyndec Pharmaceutical Co., Ltd.	1.03 Billion CNY	99.891%
Shanghai Yizhong Pharmaceutical Co., Ltd.	- CNY	-Infinity%
Sichuan Huiyu Pharmaceutical Co., Ltd.	2.04 Million CNY	45.056%
Jiangsu Lianhuan Pharmaceutical Co., Ltd.	82.91 Million CNY	98.643%

Global Stocks Search

Tibet Rhodiola Pharmaceutical Holding Co. (600211.SS)

Long Term Debt Summary of Tibet Rhodiola Pharmaceutical Holding Co.

Annual Long Term Debt Chart of Tibet Rhodiola Pharmaceutical Holding Co. (2023 - 1996)

Historical Annual Long Term Debt of Tibet Rhodiola Pharmaceutical Holding Co. (2023 - 1996)

Peer Long Term Debt Comparison of Tibet Rhodiola Pharmaceutical Holding Co.